EGFR and cervical cancer: In the present study, to investigate the combined effect of nimotuzumab-mediated EGFR blockade and radiotherapy on E6-promoted cervical cancer growth, we established an HPV-E6–overexpressing C33A cervical squamous cell line and a nude mouse model bearing these cells.